Fund+

Fund+

Fund+

Follow us
Latest investments Show all
€40,000,000
Venture capital (Series A)
Egle Therapeutics
€38,000,000
Venture capital (Series B)
Indigo Diabetes
Team Size
1–10
Employees
Past year's investments

Fund+ participated in fewer than 3 rounds over the past year

Latest rounds
  • Egle Therapeutics: Venture capital (Series A) (€40M)
  • Indigo Diabetes: Venture capital (Series B) (€38M)
  • eTheRNA Immunotherapies: Venture capital (Series B) (€34M)